|
InviraseDrug - Invirase The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Saquinavir Mesylate
Strength -
EQ 500MG BASE
Applicant -
ROCHE
New Drug Application (NDA) Number -
021785
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Dec 17, 2004
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Hoffmann La Roche Inc
Invirase
Liposyn Ii 20% 10%;10% (10gm/100ml) Injectable; Injection
Serevent Eq 0.021mg Base/inh Aerosol, Metered; Inhalation Serevent Eq 0.046mg Base/inh Powder; Inhalation Quadramet 50mci/ml Injectable; Injection Fortovase 200mg Capsule; Oral Invirase Eq 200mg Base Capsule; Oral Invirase Eq 500mg Base Tablet; Oral Liposyn 10% 10% (10gm/100ml) Injectable; Injection Liposyn 20% 20% (20gm/100ml) Injectable; Injection Liposyn Ii 10% 5%;5% (5gm/100ml) Injectable; Injection NewDrugInformation |